OpenAI is preparing to confidentially file for a U.S. initial public offering in the coming weeks, a source familiar with the matter said on Wednesday, adding to a wave of blockbuster ‌listings ...
Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results